"Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary.
Gynecol. Oncol., Oct;103(1):329-35 (2006)
Total laparoscopic hysterectomy with pelvic/aortic lymph node dissection for endometrial cancer--a consecutive series without case selection and comparison to laparotomy.
Gynecol. Oncol., May;117(2):216-23 (2010)
Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer.
Gynecol. Oncol., Feb;100(2):344-8 (2006)
The impact of subspecialty training on the management of advanced ovarian cancer.
Gynecol. Oncol., Nov;47(2):203-9 (1992)
Laparoscopic radical hysterectomy (type III) with aortic and pelvic lymphadenectomy in patients with stage I cervical cancer: surgical morbidity and intermediate follow-up.
Am. J. Obstet. Gynecol., Aug;187(2):340-8 (2002)
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study.
Gynecol. Oncol., Aug;90(2):390-6 (2003)
The relative importance of surgical training and laboratory research in a gynecologic oncology fellowship.
Int. J. Gynecol. Cancer., 14(1):23-34 (2004)
Laparoscopic modified radical hysterectomy: a strategy for a clinical dilemma.
Gynecol. Oncol., Feb;96(2):484-9 (2005)
Division of pedicles by stapling during cytoreductive surgery for ovarian cancer.
Gynecol. Oncol., Jun;97(3):852-7 (2005)
Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays.
Gynecol. Oncol., Sep;110(3):360-4 (2008)
The clinical significance of blood transfusion at the time of radical hysterectomy.
Obstet Gynecol., Jul;76(1):110-3 (1990)
What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
Gynecol. Oncol., Sep;82(3):489-97 (2001)
Ureteral obstruction and hydronephrosis as a complication of tuboovarian abscess. A case report.
J Reprod Med., Oct;33(10):835-7 (1988)
Modified posterior exenteration for ovarian cancer.
Obstet Gynecol., Nov;78(5 Pt 1):879-85 (1991)
Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival.
Gynecol. Oncol., Nov;51(2):224-9 (1993)
Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study.
Cancer., Nov;76(9):1606-14 (1995)
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Gynecol. Oncol., May;69(2):103-8 (1998)
Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Am. J. Obstet. Gynecol., Jun;182(6):1321-7 (2000)